Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013 Aug; 24(8):1227-34.
View in:
PubMed
subject areas
Aged
Aged
Bile Duct Neoplasms
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Bile Ducts, Intrahepatic
Cholangiocarcinoma
Cholangiocarcinoma
Disease Progression
Disease Progression
Embolization, Therapeutic
Embolization, Therapeutic
Female
Female
Hepatectomy
Hepatectomy
Humans
Humans
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Liver Neoplasms
Liver Neoplasms
Male
Male
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Neoadjuvant Therapy
Neoadjuvant Therapy
Proportional Hazards Models
Proportional Hazards Models
Radiopharmaceuticals
Radiopharmaceuticals
Radiotherapy, Adjuvant
Radiotherapy, Adjuvant
Retrospective Studies
Retrospective Studies
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Yttrium Radioisotopes
Yttrium Radioisotopes